Study identifier:NIS-RKR-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly
asthma
-
No
-
All
297
Observational
60 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly
Location
Location
Suwon, Gyeonggi-do, Republic of Korea
Location
Busan, Gyeonsangnam-do, Republic of Korea
Location
Changwon, Gyeonsangnam-do, Republic of Korea
Location
Wonju, Gangwon-do, Republic of Korea
Location
Anyang, Gyeonggi-do, Republic of Korea
Arms | Assigned Interventions |
---|---|
1 Total 300 subjects who was diagnosed with asthma | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.